Jan 20, 2022 | Featured, Medicare Part D, Statements
WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Department of Health and Human Services’ new report on prescription drug affordability for Medicare Part D patients: “Action must be taken to make...
Jan 18, 2022 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss a new threat to chronic disease patients in Oregon. The state is seeking a Medicaid waiver to limit patient access to medications. Specifically, the plan would incorporate the flawed quality of life-years metric to...
Jan 14, 2022 | Public Statement
Proposed decision will Exacerbate Health Inequities, Undermine FDA WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Centers for Medicare and Medicaid Service proposed decision on the national coverage...
Jan 12, 2022 | Statements
WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement on last week’s proposed CMS Rule, touted to lower costs for Medicare Part D beneficiaries at the pharmacy counter by giving patients the pharmacy price concessions...
Jan 10, 2022 | Featured, Podcast
On this episode of the podcast, the premiere episode of the third season, Terry and Bob discuss telehealth’s promise and how it can keep patients safe during the pandemic. Covid-19 proved that everyday telehealth was possible. But it also serves a vital role...
Jan 7, 2022 | FDA, Letters Submitted
The FDA’s Accelerated Approval Program provides a path for earlier approval of drugs being developed to treat serious diseases and address unmet medical need. The process allows the use of a surrogate endpoint—an indirect marker of clinical benefit that allows the...
Jan 7, 2022 | FDA, Letters Submitted
On behalf of Patients Rising, the organization representing millions of Americans living with chronic disease, I write to support the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug Administration. The U.S. Food and Drug Administration...
Jan 5, 2022 | Featured, Terry's Hot Take
Happy New Year, Terry’s Hot Take is a monthly resource for lawmakers by the Executive Director of Patients Rising, on behalf of the 133 million Americans living with chronic disease. Patients Rising NOW Supports FDA Commissioner Nominee Dr. Robert Califf: Patients...
Jan 4, 2022 | Featured, Podcast
On this episode of the podcast, the finale of Season 2, Terry and Bob discuss the health political outlook for 2022. For the chronic disease community, 2022 is set to be a major year of health policy. Republican and Democrat political experts weigh in on what’s on the...
Dec 30, 2021 | Access, Featured
In its second season, Patients Rising’s podcast has witnessed tremendous growth as we continue our coverage of topics that affect affordability and access to treatments and services, and dive into policy matters that regulate access and affordability. Here are a few...
